Organon & Co. logo

Organon & Co.

NYSE:OGN

Overview | Financials
Company Name Organon & Co.
Symbol OGN
Currency USD
Price 21.77
Market Cap 5,598,612,670
Dividend Yield 5.25%
52-week-range 10.835 - 24.08
Industry Drug Manufacturers—General
Sector Healthcare
CEO Mr. Kevin Ali
Website https://www.organon.com

An error occurred while fetching data.

About Organon & Co.

Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such

Related Stocks

Universal Health Services, Inc. logo

Universal Health Services, Inc.

UHS

181.41 USD

DaVita Inc. logo

DaVita Inc.

DVA

140.93 USD

Biohaven Pharmaceutical Holding Company Ltd. logo

Biohaven Pharmaceutical Holding Company Ltd.

BHVN

39.32 USD

Qiagen N.V. logo

Qiagen N.V.

QGEN

45.47 USD

Elanco Animal Health Incorporated logo

Elanco Animal Health Incorporated

ELAN

17 USD

Charles River Laboratories International, Inc. logo

Charles River Laboratories International, Inc.

CRL

223.06 USD

agilon health, inc. logo

agilon health, inc.

AGL

5.36 USD

Financials

Numbers are in millions USD

Numbers are in millions USD